Publication:
Relative proteome quantification of alpha, beta, gamma and delta globin chains in early eluting peaks of Bio-Rad variant II<sup>®</sup> CE-HPLC of hemoglobin from healthy and beta-thalassemia subjects in Malaysia

dc.contributor.authorUday Younis Hussein Abdullahen_US
dc.contributor.authorHishamshah M. Ibrahimen_US
dc.contributor.authorHaitham Muhammed Jassimen_US
dc.contributor.authorMohamad Zaki Sallehen_US
dc.contributor.authorTeh Lay Keken_US
dc.contributor.authorMohd Nur Fakhruzzaman bin Noorizhaben_US
dc.contributor.authorBin Alwi Zilfalilen_US
dc.contributor.authorPrapin Wilairaten_US
dc.contributor.authorSuthat Fucharoenen_US
dc.contributor.otherUniversiti Sultan Zainal Abidinen_US
dc.contributor.otherKuala Lumpur Hospitalen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherUniversiti Teknologi MARAen_US
dc.contributor.otherSchool of Medical Sciences - Universiti Sains Malaysiaen_US
dc.contributor.otherSouth Metropolitan Health Serviceen_US
dc.date.accessioned2020-01-27T07:42:34Z
dc.date.available2020-01-27T07:42:34Z
dc.date.issued2019-07-01en_US
dc.description.abstract© 2019 This is the first report of QQQ-mass spectrometric identification and quantification of the Hb subunits, alpha, beta, delta and gamma globin peptides, derived from enzymatic-digestion of proteins in the early unknown peaks of the Bio-Rad cation-exchange chromatography of haemoglobin. The objectives were to assess the relationship of the quantity of the free alpha, beta, delta and gamma globin chains with the phenotypic diversity of beta-thalassaemias (β-thal). The results demonstrate that the pools of free globin chains in red blood cells were correlating with the severity of the disease in patients with different phenotypes of β-thal. The mechanism and the regulation of synthesis of free globin chains pool in a normal individual and in patients with different β-thal phenotypes could arise from several mechanisms which will require further investigation. The role of the free globin pool in patients with β-thal for development of novel therapeutic approaches based on these potential targets requires further investigation. Pertinent biomarkers improves the diagnosis of the β-thal, especially in low-income countries where they are most common and allows more effective therapeutic intervention leading to more successful therapeutic outcome.en_US
dc.identifier.citationBiochemistry and Biophysics Reports. Vol.18, (2019)en_US
dc.identifier.doi10.1016/j.bbrep.2019.100635en_US
dc.identifier.issn24055808en_US
dc.identifier.other2-s2.0-85064628676en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/50144
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85064628676&origin=inwarden_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.titleRelative proteome quantification of alpha, beta, gamma and delta globin chains in early eluting peaks of Bio-Rad variant II<sup>®</sup> CE-HPLC of hemoglobin from healthy and beta-thalassemia subjects in Malaysiaen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85064628676&origin=inwarden_US

Files

Collections